Trials / Unknown
UnknownNCT04252963
Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)
Double-blind, Randomized, Placebo Controlled, Multicenter, Phase IV Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet (Streptokinase • Streptodornase) in Patients With Acute Upper Respiratory Infection or Acute Bronchitis
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 346 (estimated)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A phase 4 study to evaluate efficacy and safety of MUCOLASE tablet (streptokinase • streptodornase)
Detailed description
Double-blind, randomized, placebo controlled, multicenter, phase 4 clinical trial to assess the efficacy and safety of MUCOLASE tablet (streptokinase • streptodornase) in patients with acute upper respiratory infection or acute bronchitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MUCOLASE tablet (streptokinase • streptodornase) | streptokinase • streptodornase 5mg |
| DRUG | Placebo | Placebo of MUCOLASE tablet |
Timeline
- Start date
- 2018-11-02
- Primary completion
- 2021-02-01
- Completion
- 2021-05-01
- First posted
- 2020-02-05
- Last updated
- 2020-02-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04252963. Inclusion in this directory is not an endorsement.